These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30691475)

  • 1. Clinicopathological and prognostic values of fibronectin and integrin αvβ3 expression in primary osteosarcoma.
    Shi K; Wang SL; Shen B; Yu FQ; Weng DF; Lin JH
    World J Surg Oncol; 2019 Jan; 17(1):23. PubMed ID: 30691475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
    Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
    Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.
    Zhu H; Cai H; Tang M; Tang J
    Clin Transl Oncol; 2014 Aug; 16(8):732-8. PubMed ID: 24338507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
    Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
    Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma.
    Yuan D; Liu B; Liu K; Zhu G; Dai Z; Xie Y
    J Surg Oncol; 2013 Sep; 108(3):157-62. PubMed ID: 23813624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasculogenic mimicry: a new prognostic sign of human osteosarcoma.
    Ren K; Yao N; Wang G; Tian L; Ma J; Shi X; Zhang L; Zhang J; Zhou X; Zhou G; Wu S; Sun X
    Hum Pathol; 2014 Oct; 45(10):2120-9. PubMed ID: 25123071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
    Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M
    Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
    Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
    Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases.
    Righi A; Gambarotti M; Sbaraglia M; Sisto A; Ferrari S; Dei Tos AP; Picci P
    Hum Pathol; 2016 Dec; 58():15-23. PubMed ID: 27544803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
    Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
    Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of long non-coding RNA EWSAT1 as a novel prognostic biomarker in osteosarcoma.
    Zhang GY; Zhang JF; Hu XM; Luo ZP; Ma YZ
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5337-5341. PubMed ID: 29243774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
    Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
    Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
    Huang H; Zheng HY; Liu ZL; Zhang L
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-4 and fibronectin in osteosarcoma.
    Na KY; Bacchini P; Bertoni F; Kim YW; Park YK
    Pathology; 2012 Jun; 44(4):325-30. PubMed ID: 22531343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
    Zhao C; Li H; Wang L; Sun W
    Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.